Endothelial dysfunction in diabetes mellitus

References

• AanderudSKraneHNordoyAInfluence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cellsDiabetologia19852864143905474
   PubMed Web of Science ®Google Scholar
• Al SuwaidiJHiganoSTHolmesDRObesity is an independent predictor of coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteriesJ Am Coll Cardiol200137152311345360
   PubMed Web of Science ®Google Scholar
• AmetovASDemidovaTIuKosykhSANO synthesis in the vascular endothelium of patients with type II diabetesKlin Med (Mosk)200583862816218368
   PubMedGoogle Scholar
• AmmarRFJrGuttermanDDBrooksLAFree radicals mediate endothelial dysfunction of coronary arterioles in diabetesCardiovasc Res20004759560110963732
   PubMed Web of Science ®Google Scholar
• AndersonTJAssessment and treatment of endothelial dysfunction in humansJ Am Coll Cardiol199934631810483941
   PubMed Web of Science ®Google Scholar
• AndersonTJElsteinEHaberHComparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)J Am Coll Cardiol20003560610636260
   PubMed Web of Science ®Google Scholar
• AndersonTJUehataAGerhardMDClose relation of endothelial function in the human coronary and peripheral circulationsJ Am Coll Cardiol1995261235417594037
   PubMed Web of Science ®Google Scholar
• AngCHillierCJohnstonFEndothelial function is preserved in pregnant women with well-controlled type 1 diabetesBJOG200210969970712118651
   PubMed Web of Science ®Google Scholar
• AnsellBJWatsonKEWeissREhsCRP and HDL Effects of Statins Trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels. A clinical investigationHeart Dis200352712549983
   PubMedGoogle Scholar
• ArbogastBWLeeGMRaymondTLIn vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serumDiabetes19823159396819172
   PubMed Web of Science ®Google Scholar
• ArcaroGCrettiABalzanoSInsulin causes endothelial dysfunction in humans: sites and mechanismsCirculation20021055768211827922
   PubMed Web of Science ®Google Scholar
• ArcaroGZenereBMSaggianiFACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuriaDiabetes Care19992215364210480522
   PubMed Web of Science ®Google Scholar
• ArnerPThe adipocyte in insulin resistance: key molecules and impact of the thiazolidinedionesTrends Endocrinol Metab2003141374512670740
   PubMed Web of Science ®Google Scholar
• AvenaRMitchellMENylenESInsulinaction enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetesJ VascSurg199828102432
   PubMed Web of Science ®Google Scholar
• AvogaroACaloLPiarulliFEffect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxideDiabetes199948391710334319
   PubMedGoogle Scholar
• AvogaroAFadiniGPGalloAEndothelial dysfunction in type 2 diabetes mellitusNutr Metab Cardiovasc Dis200616Suppl 1S394516530129
   PubMedGoogle Scholar
• AvogaroAMiolaMFavaroAGemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patientsEur J Clin Invest200131603911454015
   PubMed Web of Science ®Google Scholar
• BagiZKollerAKaleyGPeroxisome proliferator-activated receptor activation increases NO bioavailability in coronary arterioles in type 2 diabetes by reducing oxidative stressAm J Physiol HeartCirc Physiol2004286H7428
   PubMed Web of Science ®Google Scholar
• BalletshoferBMRittigKEnderleMDEndothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistanceCirculation20001011780410769277
   PubMed Web of Science ®Google Scholar
• BastaGDel TurcoSDe CaterinaRAdvanced glycation endproducts: implications for accelerated atherosclerosis in diabetesRecenti Prog Med200495678015072391
   PubMedGoogle Scholar
• BeishuizenEDTamsmaJTJukemaJWThe effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular diseaseDiabetes Care20052816687415983318
   PubMed Web of Science ®Google Scholar
• BengelFMAbletshauserCNeverveJEffects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus – a randomized study using positron emission tomographyDiabet Med2005221586315660732
   PubMed Web of Science ®Google Scholar
• BhargavaKHansaGBansalMEndothelium-dependent brachial artery flow mediated vasodilatation in patients with diabetes mellitus with and without coronary artery diseaseJ Assoc Physicians India200351355812723648
   PubMedGoogle Scholar
• BiegelsenESLoscalzoJEndothelial function and atherosclerosisCoron Artery Dis1999102415610376203
   PubMed Web of Science ®Google Scholar
• BijlstraPJSmitsPLuttermanJAEffect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndromeJ Cardiovasc Pharmacol199525658647596136
   PubMed Web of Science ®Google Scholar
• BilsboroughWO’DriscollGStantonKEffect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetesClin Sci (Lond)2002103163912149108
   PubMed Web of Science ®Google Scholar
• Bishop-BaileyDPeroxisome proliferator-activated receptors in the cardiovascular systemBr J Pharmacol20001298233410696077
   PubMed Web of Science ®Google Scholar
• BlairAShaulPWYuhannaISOxidized low-density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activationJ Biol Chem1999274325121910542298
   PubMed Web of Science ®Google Scholar
• BloomgardenZTEndothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunctionDiabetes Care19982118399538990
   PubMed Web of Science ®Google Scholar
• BodenGShulmanGIFree fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta celldysfunctionEur J Clin Invest200232Suppl 3142312028371
   PubMed Web of Science ®Google Scholar
• BonnerGHyperinsulinemia, insulin resistance, and hypertensionJ Cardiovasc Pharmacol199424Suppl 2S39497898093
   PubMedGoogle Scholar
• BoothGStalkerTJLeferAMMechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivoDiabetes20025115566411978656
   PubMed Web of Science ®Google Scholar
• BrinerVALuscherTFRole of vascular endothelial abnormalities in clinical medicine: atherosclerosis, hypertension, diabetes, and endotoxemiaAdv Intern Med1994391228140952
   PubMedGoogle Scholar
• BusseRFlemingIHeckerMSignal transduction in endothelium-dependent vasodilatationEur Heart J199314Suppl I298293777
   PubMedGoogle Scholar
• CaballeroAEAroraSSaouafRMicrovascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetesDiabetes19994818566210480619
   PubMed Web of Science ®Google Scholar
• CaballeroAESaouafRLimSCThe effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trialMetabolism2003521738012601628
   PubMed Web of Science ®Google Scholar
• CacoubPCarayonADorentREndothelin: the vasoconstrictor of the 1990’s?Rev Med Interne199314229328378653
   PubMed Web of Science ®Google Scholar
• Calles-EscandonJBallorDHarvey-BerinoJAmelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restrictionAm J Clin Nutr1996647118669417
   PubMed Web of Science ®Google Scholar
• CardilloCCampiaUBryantMBIncreased activity of endogenous endothelin in patients with type II diabetes mellitusCirculation20021061783712356630
   PubMed Web of Science ®Google Scholar
• CerielloACavarapeAMartinelliLThe post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspartDiabet Med200421171514984453
   PubMed Web of Science ®Google Scholar
• ChanJRBogerRHBode-BogerSMAsymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humansArterioscler Thromb Vasc Biol2000201040610764670
   PubMed Web of Science ®Google Scholar
• ChappeyOWautierMPBovalBEndothelial cells in culture: an experimental model for the study of vascular dysfunctionsCell Biol Toxicol1996121992059034609
   PubMed Web of Science ®Google Scholar
• CharvatJMichalovaKChlumskyJThe association between left ventricle diastolic dysfunction and endothelial dysfunction and the results of stress myocardial SPECT in asymptomatic patients with type 2 diabetesJ Int Med Res2005334738216222880
   PubMed Web of Science ®Google Scholar
• ChaturvediNFullerJHPokrasFCirculating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibitionDiabet Med2001182889411437859
   PubMed Web of Science ®Google Scholar
• CheethamCO’DriscollGStantonKLosartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetesClin Sci (Lond)2001100131711115412
   PubMed Web of Science ®Google Scholar
• CheethamsCCollisJO’DriscollGLosartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetesJ Am Coll Cardiol2000361461611079643
   PubMed Web of Science ®Google Scholar
• ChenX-LTummalaPEOlbrychMTAngiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cellsCirc Res19988395299797345
   PubMed Web of Science ®Google Scholar
• ChiarelliFPomilioMMohnAHomocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathyJ Pediatr20001373869210969265
   PubMed Web of Science ®Google Scholar
• ChicoAPerezACordobaAPlasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?Diabetologia199841684939662051
   PubMed Web of Science ®Google Scholar
• ChowienczykPJBrettSEGopaulNKOral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetesDiabetologia200043974710990073
   PubMed Web of Science ®Google Scholar
• CipollaMJElevated glucose potentiates contraction of isolated rat resistance arteries and augments protein kinase C-induced intracellular calcium releaseMetabolism19994810152210459567
   PubMed Web of Science ®Google Scholar
• ClarksonPCelermajerDSDonaldAEImpaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levelsJ Am Coll Cardiol19962857398772741
   PubMed Web of Science ®Google Scholar
• ClelandSJPetrieJRSmallMInsulin action is associated with endothelial function in hypertension and type 2 diabetesHypertension2000351 Pt 25071110642350
   PubMed Web of Science ®Google Scholar
• ClemensAKlevesathMSHofmannMOctreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitusMetabolism19994812364010535384
   PubMed Web of Science ®Google Scholar
• CongerJDEndothelial regulation of vascular toneHosp Pract19942911726 (Off Ed)
   Web of Science ®Google Scholar
• ContrerasFDiabetes and hypertension physiopathology and therapeuticsJ Hum Hypertens200014S263110854077
   PubMed Web of Science ®Google Scholar
• CostaACasamitjanaRCasalsEEffects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucoseDiabet Med200320743512925055
   PubMed Web of Science ®Google Scholar
• CostacouTLopes-VirellaMFZgiborJCMarkers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications StudyJ Diabetes Complications2005191839315993351
   PubMed Web of Science ®Google Scholar
• CotellessaMMinnitiGCeroneRLow total plasma homocysteine concentrations in patients with type 1 diabetesDiabetes Care2001249697111347774
   PubMedGoogle Scholar
• CowanDBLangilleBLCellular and molecular biology of vascular remodelingCurr Opin Lipidol19967941008743902
   PubMed Web of Science ®Google Scholar
• CroninCCMcPartlinJMBarryDGPlasma homocysteine concentrations in patients with type 1 diabetesDiabetes Care199821184379802731
   PubMedGoogle Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• Dalla NoraEPassaroAZamboniPFAtorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled studyJ Endocrinol Invest20032673812602538
   PubMed Web of Science ®Google Scholar
• DandonaPAljadaAEndothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agentsJ Diabetes Complications2004189110215120703
   PubMed Web of Science ®Google Scholar
• DarkoDDornhorstAKellyFJLack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetesClin Sci (Lond)20021033394412241530
   PubMed Web of Science ®Google Scholar
• DayCThiazolidinediones: a new class of antidiabetic drugsDiabet Med1999161799210227562
   PubMed Web of Science ®Google Scholar
• De CobelliFFiorinaPPerseghinGL-arginine-induced vasodilation of the renal vasculature is preserved in uremic type 1 diabetic patients after kidney and pancreas but not after kidney-alone transplantationDiabetes Care2004279475415047654
   PubMed Web of Science ®Google Scholar
• De MattiaGBraviMCLaurentiOReduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetesDiabetologia199841139269833950
   PubMed Web of Science ®Google Scholar
• De MattiaGLaurentiOFavaDDiabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patientsJ Diabetes Complication2003172 Suppl305
   PubMed Web of Science ®Google Scholar
• De MeyerGRHermanAGVascular endothelial dysfunctionProg Cardiovasc Dis199739325429050818
   PubMed Web of Science ®Google Scholar
• De VrieseASVerbeurenTJde VoordeJVEndothelial dysfunction in diabetesBritish Journal of Pharmacology20001309637410882379
   PubMed Web of Science ®Google Scholar
• DeanfieldJDonaldAFerriCEndothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of HypertensionJ Hypertens20052371715643116
   PubMed Web of Science ®Google Scholar
• DheinSKabatAOlbrichAEffect of chronic treatment with vitamin E on endothelial dysfunction in a type I in vivo diabetes mellitus model and in vitroJ Pharmacol Exp Ther20033051142212649359
   PubMed Web of Science ®Google Scholar
• DograGRichLStantonKEndothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuriaDiabetologia20014459360111380077
   PubMed Web of Science ®Google Scholar
• DosquetCWautierMPGuillausseauPJMonokines and endothelial cell proliferation in patients with diabetes mellitusDiabete Metab19942037428056134
   PubMed Web of Science ®Google Scholar
• DrabMVerkadePElgerMLoss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted miceScience200129324495211498544
   PubMed Web of Science ®Google Scholar
• DukaIShenoudaSJohnsCRole of the B(2) receptor of bradykinin in insulin sensitivityHypertension20013813556011751717
   PubMed Web of Science ®Google Scholar
• DumontASHyndmanMEDumontRJImprovement of endothelial function in insulin-resistant carotid arteries treated with pravastatinJ Neurosurg2001954667111565869
   PubMed Web of Science ®Google Scholar
• DzauVJTissue angiotensin and pathobiology of vascular disease: a unifying hypothesisHypertension20013710475211304501
   PubMed Web of Science ®Google Scholar
• ElliotTGCockcroftJRGroopPHInhibition of nitric oxide synthesis in forearm vasculature of insulin-dependentdiabetic patients: blunted vasosonstriction on patients with microalbuminuriaClin Sci (Lond)199385687938287660
   PubMed Web of Science ®Google Scholar
• EvansMAndersonRAGrahamJCiprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitusCirculation20001011773910769276
   PubMed Web of Science ®Google Scholar
• EvansMAndersonRASmithJCEffects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitusEur J Clin Invest200333231812641541
   PubMed Web of Science ®Google Scholar
• FantuzziGFaggioniRLeptin in the regulation of immunity, inflammation, and hematopoiesisJ Leukoc Biol2000684374611037963
   PubMed Web of Science ®Google Scholar
• FarhangkhoeeHKhanZAKaurHVascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targetsPharmacol Ther20061113849916343639
   PubMed Web of Science ®Google Scholar
• FarouqueHMMeredithITThe assessment of endothelial function in humansCoron Artery Dis2001124455411696683
   PubMed Web of Science ®Google Scholar
• FaschingPVeitlMRohacMElevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitusJ Clin Endocrinol Metab1996814313178954033
   PubMed Web of Science ®Google Scholar
• FeganPGShoreACMawsonDMicrovascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapyDiabet Med2005221670616401310
   PubMed Web of Science ®Google Scholar
• ForstTLubbenGHohbergCInfluence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2Microcirculation2005125435016207627
   PubMed Web of Science ®Google Scholar
• FreedMIRatnerRMarcovinaSMEffects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitusAm J Cardiol2002909475212398960
   PubMed Web of Science ®Google Scholar
• Fuchsjager-MayrlGPleinerJWiesingerGFExercise training improves vascular endothelial function in patients with type 1 diabetesDiabetes Care200225179580112351480
   PubMed Web of Science ®Google Scholar
• GabouryCLSimonsonDCSeelyEWRelation of pressor responsiveness to angiotensin II and insulin resistance in hypertensionJ Clin Invest19949422953007989585
   PubMed Web of Science ®Google Scholar
• GaenzerHNeumayrGMarschangPEffect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitusAm J Cardiol200289431411835925
   PubMed Web of Science ®Google Scholar
• Garcia SorianoFViragLJagtapPDiabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activationNat Med200171081311135624
   PubMed Web of Science ®Google Scholar
• GasicSWagnerOFFaschingPFosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuriaAm J Hypertens1999122 Pt 12172210090351
   PubMed Web of Science ®Google Scholar
• GazisAWhiteDJPageSREffect of oral vitamin E (α-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitusDiabet Med1999163041110220204
   PubMed Web of Science ®Google Scholar
• GlowinskaBUrbanMPeczynskaJSelected adhesion molecules: sICAM-1 and sVCAM-1 as markers of endothelial dysfunction in diabetic children and adolescencePol Merkuriusz Lek2003142059
   PubMedGoogle Scholar
• GoldinECasadevallMMourelleMRole of prostaglandins and nitric oxide in gastrointestinal hyperemia of diabetic ratsAm J Physiol1996270G684908928799
   PubMedGoogle Scholar
• GoranMIBallGDCruzMLObesity and risk of type 2 diabetes and cardiovascular disease in children and adolescentsJ Clin Endocrinol Metab20038814172712679416
   PubMed Web of Science ®Google Scholar
• HaefligerIOFlammerJLuscherTFNitric oxide and endothelin-1 are important regulators of human ophthalmic arteryInvest Ophthalmol Vis Sci199233234031607246
   PubMed Web of Science ®Google Scholar
• HadiARHCarrCSAl SuwaidiJEndothelial dysfunction: cardiovascular risk factors, therapy and outcomeVascular Health and Risk Management200511839817319104
   PubMedGoogle Scholar
• HaffnerSMPre-diabetes, insulin resistance, inflammation and CVD riskDiabetes Res Clinc Pract200361Suppl 1S918
   PubMedGoogle Scholar
• HallerHEndothelial function. General considerationsDrugs199753Suppl 11109034750
   PubMedGoogle Scholar
• HattoriYKasaiKNakamuraTEffect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cellsMetabolism19914016591988773
   PubMed Web of Science ®Google Scholar
• HaunerHThe mode of action of thiazolidinedionesDiabetes Metab Res Rev200218Suppl 2S101511921433
   PubMedGoogle Scholar
• HaunerHTakahashiMFunahashiTPPAR_ ligands increase expression and plasma concentrations of adiponectin, an adipose derived proteinDiabetes2001502094911522676
   PubMed Web of Science ®Google Scholar
• HazelLKennethARoebuckOOxidant stress and endothelial cell dysfunctionAm J Physiol Cell Physio2001280C71941
   PubMed Web of Science ®Google Scholar
• HednerTSunXMeasures of endothelial function as an endpoint in hypertension?Blood Press Suppl1997258669495629
   PubMedGoogle Scholar
• HenryRMFerreiraIKostensePJType 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolismis not; The Hoorn StudyAtherosclerosis2004174495615135250
   PubMed Web of Science ®Google Scholar
• HermannTSLiWDominguezHQuinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetesJ Clin Endocrinol Metab2006911001816352688
   PubMed Web of Science ®Google Scholar
• HinkUTsilimingasNWendtMMechanisms underlying endothelial dysfunction in diabetes mellitus: therapeutic implicationsEndocrinol20032293304
   Google Scholar
• HofmannMAKohlBZumbachMSHyperhomocyst(e)inemia and endothelial dysfunction in IDDMDiabetes Care19982184189589252
   PubMed Web of Science ®Google Scholar
• HonisettSYStojanovskaLSudhirKHormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazoneJ Clin Endocrinol Metab2004894615915356071
   PubMed Web of Science ®Google Scholar
• HornigBLandmesserUKohlerCComparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutaseCirculation200110379980511171786
   PubMed Web of Science ®Google Scholar
• HsuehWAAndersonPWHypertension, the endothelial cell, and the vascular complications of diabetes mellitus [clinical conference]Hypertension199220253631639468
   PubMed Web of Science ®Google Scholar
• HsuehWAAndersonPWSystemic hypertension and the renin-angiotensin system in diabetic vascular complicationsAm J Cardiol19937214H21H8517422
   PubMed Web of Science ®Google Scholar
• HsuehALyonJManuelJInsulin resistance and the endotheliumAm J Med20041171091715234647
   PubMed Web of Science ®Google Scholar
• HubacekJVermaSShewchukLRationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetesCan J Cardiol20042014495315614340
   PubMed Web of Science ®Google Scholar
• HultbergBAgardhEAnderssonAIncreased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitusScand J Clin Lab Invest199151277821882179
   PubMed Web of Science ®Google Scholar
• HuversFCDe LeeuwPWHoubenAJEndothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditionsDiabetes1999481300710342820
   PubMed Web of Science ®Google Scholar
• JankaHUPlatelet and endothelial function tests during metformin treatment in diabetes mellitusHorm Metab Res Suppl19851512022934311
   PubMedGoogle Scholar
• JarvisaloMJRaitakariMToikkaJOEndothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetesCirculation20041091750515023875
   PubMed Web of Science ®Google Scholar
• JensenSMicroalbuminuria and risk of atherosclerosis. Clinical epidemiological and physiological investigatorsDan Med Bull200047637810822799
   PubMedGoogle Scholar
• JohnstoneMTCreagerSJScalesKMimpaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitusCirculation1993882510168080489
   PubMed Web of Science ®Google Scholar
• JorgeC-EMarilynCDiabetes and endothelial dysfunction: a clinical perspectiveEndocrine Reviews200122365211159815
   PubMed Web of Science ®Google Scholar
• JoyceMMooreKThompsonCHydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetesEur J Vasc Endovasc Surg200427432715015196
   PubMed Web of Science ®Google Scholar
• KabatADheinSL-arginine supplementation prevents the development of endothelial dysfunction in hyperglycaemiaPharmacology2006761859116491042
   PubMed Web of Science ®Google Scholar
• KahnBBFlierJSObesity and insulin resistanceJ Clin Invest20001064738110953022
   PubMed Web of Science ®Google Scholar
• KamideKNaganoMNakanoNInsulin resistance and cardiovascular complications in patients with essential hypertensionAm J Hypertens199691165718972886
   PubMed Web of Science ®Google Scholar
• KatakamPVUjhelyiMRHoenigMMetformin improves vascular function in insulin-resistant ratsHypertension2000351 Pt 11081210642283
   PubMed Web of Science ®Google Scholar
• KeechAColquhounDBestJSecondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trialDiabetes Care20032627132114514569
   PubMed Web of Science ®Google Scholar
• KhderYBrianconSPetermannRShear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type II diabetesJ Hypertens1998161619259856362
   PubMed Web of Science ®Google Scholar
• KimSHParkKWKimYSEffects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolismEndothelium200310657012791513
   PubMed Web of Science ®Google Scholar
• KimY-BCiaraldiTPKongATroglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110_ protein levels in skeletal muscle of type 2 diabetic subjectsDiabetes200251443811812753
   PubMed Web of Science ®Google Scholar
• KingHAubertREHermanWHGlobal burden of diabetes, 1995–2025: prevalence, numerical estimates and projectionsDiabetes Care1998211414319727886
   PubMed Web of Science ®Google Scholar
• KitaTKumeNMinamiMRole of oxidized LDL in atherosclerosisAnn NY Acad Scie2001947199206
   PubMed Web of Science ®Google Scholar
• KohMSMajewskiBBRhodesELDiabetic serum stimulates the proliferation of endothelial cells in cultureDiabetes Res1985228794075699
   PubMedGoogle Scholar
• KonukogluDDoganETurhanMSImpaired glucose tolerance: its relevance to early endothelial dysfunctionHorm Metab Res2003356071014605996
   PubMed Web of Science ®Google Scholar
• KruszynskaYTYuJGOlefskyJMEffects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjectsDiabetes200049633910871202
   PubMed Web of Science ®Google Scholar
• KubokiKJiangZYTakaharaNRegulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulinCirculation20001016768110673261
   PubMed Web of Science ®Google Scholar
• LandinKTengbornLSmithUElevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular diseaseJ Intern Med199022727382182759
   PubMed Web of Science ®Google Scholar
• LebovitzHEDoleJFPatwardhanRRosiglitazone monotherapy is effective in patients with type 2 diabetesJ Clin Endocrinol Metab200186280811232013
   PubMed Web of Science ®Google Scholar
• LeinonenEHurt-CamejoEWiklundOInsulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetesAtherosclerosis20031663879412535753
   PubMed Web of Science ®Google Scholar
• LemneCde FaireUElevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbancesEur J Clin Invest19962669278872066
   PubMed Web of Science ®Google Scholar
• LeursPBStolkRPHamulyakKTissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetesDiabetes Care2002251340512145232
   PubMed Web of Science ®Google Scholar
• LevinEREndothelins as cardiovascular peptidesAmJ Nephrol199616246518739884
   PubMed Web of Science ®Google Scholar
• LibbyPInflammation in atherosclerosisNature20024208687412490960
   PubMed Web of Science ®Google Scholar
• LimACVasculopathy in type 2 diabetic individuals without microalbumuriaDiabetes Care19992218657010546021
   PubMed Web of Science ®Google Scholar
• LoomansCJde KoningEJStaalFJEndothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetesDiabetes200453195914693715
   PubMed Web of Science ®Google Scholar
• LorenziMMontisanoDFToledoSHigh glucose induces DNA damage in cultured human endothelial cellsJ Clin Invest19867732253944257
   PubMed Web of Science ®Google Scholar
• LoviscachMRehmanNCarterLDistribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin actionDiabetologia2000433041110768091
   PubMed Web of Science ®Google Scholar
• LuscherTFThe endothelium. Target and promoter of hypertension?Hypertension19901548252110114
   PubMed Web of Science ®Google Scholar
• LuscherTFTannerFCTschudiMREndothelial dysfunction in coronary artery diseaseAnnu Rev Med1993443954188476260
   PubMed Web of Science ®Google Scholar
• LyonCJLawREHsuehWAMinireview: adiposity, inflammation, and atherogenesisEndocrinology2003144219520012746274
   PubMed Web of Science ®Google Scholar
• MacKenzieKEWiltshireEJGentRFolate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitusPediatrics20061182425316818571
   PubMed Web of Science ®Google Scholar
• MaejimaKNakanoSHimenoMIncreased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complicationsJ Diabetes Complications2001151354311358682
   PubMed Web of Science ®Google Scholar
• MaioranaAO’DriscollGCheethamCThe effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetesJ Am Coll Cardiol200138860611527646
   PubMed Web of Science ®Google Scholar
• MakimattilaSVirkamakiAGroopPHChronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitusCirculation1996941276828822980
   PubMed Web of Science ®Google Scholar
• MakinoNMaedaTSuganoMHigh serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cellsJ Diabetes Complications2005193475516260352
   PubMed Web of Science ®Google Scholar
• ManciniGBHenryGCMacayaCAngiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) StudyCirculation199694258658759064
   PubMed Web of Science ®Google Scholar
• ManzellaDGrellaRAbbatecolaAMRepaglinide administration improves brachial reactivity in type 2 diabetic patientsDiabetes Care2005283667115677794
   PubMed Web of Science ®Google Scholar
• ManzellaDRagnoEAbbatecolaAMResidual C-peptide secretion and endothelial function in patients with Type II diabetesClin Sci (Lond)20031051131812608890
   PubMed Web of Science ®Google Scholar
• MatherKJVermaSAndersonTJImproved endothelial function with metformin in type 2 diabetes mellitusJ Am Coll Cardiol20013713445011300445
   PubMed Web of Science ®Google Scholar
• MatsuokaHEndothelial dysfunction associated with oxidative stress in humanDiabetes Res Clin Practice200154SupplS6572
   PubMedGoogle Scholar
• McFarlaneSIKumarASowersJRMechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovasculardiseaseAm J Cardiol20039130H37H
   PubMed Web of Science ®Google Scholar
• McFarlaneRMcCredieRJBonneyMAAngiotensin converting enzyme inhibition and arterial endothelial function in adults with type 1 diabetes mellitusDiabet Med19991662610229295
   PubMed Web of Science ®Google Scholar
• McIntyreMBohrDFDominiczakAFEndothelial function hypertension: the role of superoxide anionHypertension1999345394510523323
   PubMed Web of Science ®Google Scholar
• McSorleyPTBellPMYoungISEndothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trialDiabet Med2005227031015910620
   PubMed Web of Science ®Google Scholar
• McVeighGECohnJNEndothelial dysfunction and the metabolic syndromeCurr Diab Rep20033879212643151
   PubMedGoogle Scholar
• MeekingDRCummingsMHThorneSEndothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuriaDiabet Med199916841710547211
   PubMed Web of Science ®Google Scholar
• MeigsJBHuFBRifaiNBiomarkers of endothelial dysfunction and risk of type 2 diabetes mellitusJAMA200429119788615113816
   PubMed Web of Science ®Google Scholar
• MoldoveanuETanaseanuCTanaseanuSPlasma markers of endothelial dysfunction in type 2 diabeticsEur J Intern Med200617384216378884
   PubMed Web of Science ®Google Scholar
• MombouliJVACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxideDrugs199754Suppl 512229429841
   PubMedGoogle Scholar
• MombouliJVVanhouttePMKinins and endothelial control of vascular smooth muscleAnnu Rev Pharmacol Toxicol1995356797057598512
   PubMed Web of Science ®Google Scholar
• MoussaviNRenierGRoussinALack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetesDiabetes Obes Metab20046697714686966
   PubMed Web of Science ®Google Scholar
• MudaliarSHenryRRNew oral therapies for type 2 diabetesmellitus: the glitazones or insulin sensitizersAnnu Rev Med2001522395711160777
   PubMed Web of Science ®Google Scholar
• MullenMJClarksonRDonaldAEEffect of enalapril on endothelial function in young insulin-dependent diabetic patients: A randomized, double blind studyJ Am Coll Cardiol199831133059581728
   PubMed Web of Science ®Google Scholar
• MyrupBMathiesenERRonnBEndothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitusDiabetes Res1994263397664535
   PubMedGoogle Scholar
• NeriSBrunoCMLeottaCEarly endothelial alterations in non-insulin-dependent diabetes mellitusInt J Clin Lab Res19982810039689551
   PubMedGoogle Scholar
• NielsenFSRossingPGallMALisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathyScand J Clin Lab Invest199757427349279969
   PubMed Web of Science ®Google Scholar
• NordtTKKlassenKJSchneiderDJAugmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysisArterioscler Thromb199313182288241103
   PubMed Web of Science ®Google Scholar
• NystromTNygrenASjoholmAPersistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarctionClin Sci (Lond)2005108121815504106
   PubMed Web of Science ®Google Scholar
• O’DriscollGGreenDMaioranaAImprovement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitusJ Am Coll Cardiol19993315061110334415
   PubMed Web of Science ®Google Scholar
• O’DriscollGGreenDRankinJImprovement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitusJ Clin Invest1997100678849239416
   PubMed Web of Science ®Google Scholar
• O’DriscollGGreenDTaylorRRSimvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 monthCirculation1997951126319054840
   PubMed Web of Science ®Google Scholar
• OkonEBChungAWRauniyarPCompromised arterial function in human type 2 diabetic patientsDiabetes20055424152316046309
   PubMed Web of Science ®Google Scholar
• OkouchiMOkayamaNImaiSHigh insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinaseDiabetologia20024514495612378388
   PubMed Web of Science ®Google Scholar
• OmoriHNagashimaHTsurumiYDirect in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjectsBr J Clin Pharmacol200254395912392587
   PubMed Web of Science ®Google Scholar
• OomenPHKantGDDullaartRPAcute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunctionMicrovasc Res2002631911749067
   PubMed Web of Science ®Google Scholar
• OomenPHKantGDDullaartRPNo effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitusScand J Clin Lab Invest2004641192715115249
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSAritaYAdiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathwayCirculation2000102129630110982546
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSAritaYAdipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophagesCirculation200110310576311222466
   PubMed Web of Science ®Google Scholar
• OuvinaSMLa GrecaRDZanaroNLEndothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patientsThromb Res20011021071411323020
   PubMed Web of Science ®Google Scholar
• PaniaguaJALopez-MirandaJEscribanoACerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetesDiabetes200251259660312145176
   PubMed Web of Science ®Google Scholar
• PaolissoGGiuglianoDOxidative stress and insulin action: is there a relationship?Diabetologia199639357638721784
   PubMed Web of Science ®Google Scholar
• PaviaCFerrerIVallsCTotal homo-cysteine in patients with type 1 diabetesDiabetes Care20002384710857974
   PubMed Web of Science ®Google Scholar
• PenaASWiltshireEGentRFolic acid improves endothelial function in children and adolescents with type 1 diabetesJ Pediatr2004144500415069400
   PubMed Web of Science ®Google Scholar
• PerticoneFCeravoloRCandigliotaMObesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin CDiabetes2001501596511147782
   PubMed Web of Science ®Google Scholar
• PieperGMJordanMAdamsMBRestoration of vascular endothelial function in diabetesDiabetes Res Clin Pract199631SupplS157628864654
   PubMedGoogle Scholar
• PieperGMJordanMAdamsMBSyngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetesDiabetes1995441106137657036
   PubMed Web of Science ®Google Scholar
• PieperGMLangenstroerPSiebeneichWDiabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicalsCardiovasc Res199734145569217884
   PubMed Web of Science ®Google Scholar
• PieperGMSiebeneichWDiabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamineJ Cardiovasc Pharmacol19973073489436811
   PubMed Web of Science ®Google Scholar
• PieperGMSiebeneichWTemocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunctionEur J Pharmacol20004031293210969153
   PubMed Web of Science ®Google Scholar
• PinkneyJHDownsLHoptonMEndothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin EDiabet Med199916993910656227
   PubMed Web of Science ®Google Scholar
• PistroschFHerbrigKKindelBRosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patientsDiabete200554220611
   Google Scholar
• PistroschFPassauerJFischerSIn type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose controlDiabetes Care2004274849014747233
   PubMed Web of Science ®Google Scholar
• PlutzkyJInflammatory pathways in atherosclerosis and acute coronary syndromesAm J Cardiol200188101511423051
   PubMed Web of Science ®Google Scholar
• PrasadATupas-HabibTSchenkeWHAcute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosisCirculation200010123495410821809
   PubMed Web of Science ®Google Scholar
• PriorJOQuinonesMJHernandez-PampaloniMCoronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitusCirculation20051112291815851590
   PubMed Web of Science ®Google Scholar
• QianLBWangHPQiuWLInterleukin-2 protects against endothelial dysfunction induced by high glucose levels in ratsVascul Pharmacol2006453748216837248
   PubMed Web of Science ®Google Scholar
• QuinÜonesMJHernandez-PampaloniMChonYImprovement of coronary artery endothelial dysfunction in insulin resistant patients after treatment with insulin-sensitizing thiazolidinedionesDiabetes200251A172
   Web of Science ®Google Scholar
• RabelinkTJBakrisGLThe renin-angiotensin system in diabetic nephropathy: the endothelial connectionMiner Electrolyte Metab19982438189930377
   PubMedGoogle Scholar
• RamsayJESimmsRJFerrellWREnhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetesDiabetes Care200326475912547884
   PubMed Web of Science ®Google Scholar
• Rask-MadsenNIhlemannTKrarupEInsulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart diseaseDiabetes20015026111811679442
   PubMed Web of Science ®Google Scholar
• RegensteinerJGPopylisenSBauerTAOral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetesVasc Med200381697514989557
   PubMed Web of Science ®Google Scholar
• RizzoVMcIntoshDPOhPIn situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin associationJ Biol Chem19982733472499856995
   PubMed Web of Science ®Google Scholar
• RobillonJCanivetBCanditoMType 1 diabetes mellitus and homocyst(e)ineDiabetes Metab1994204946
   PubMed Web of Science ®Google Scholar
• SahachVFPrysiazhnaODTkachenkoMNEffect of L-arginine on the endothelium functional activity in experimental diabetes mellitusFiziol Zh20055137
   Google Scholar
• SalmiMStolenCJousilahtiPInsulin-regulated increase of soluble vascular adhesion protein-1 in diabetesAm J Pathol200216122556212466139
   PubMed Web of Science ®Google Scholar
• SatoNKaseHKatoTEffect of angiotensin II type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertensionNippon Rinsho2003611245912877092
   PubMedGoogle Scholar
• SchneiderJGTillyNHierlTElevated plasma endothelin-1 levels in diabetes mellitusAm J Hypertens2002159677212441216
   PubMed Web of Science ®Google Scholar
• ShemyakinABohmFWagnerHEnhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistanceJ Cardiovasc Pharmacol2006473859016633080
   PubMed Web of Science ®Google Scholar
• ShepherdJCobbeSMFordIPrevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupN Engl J Med1995333130177566020
   PubMed Web of Science ®Google Scholar
• ShestakovaMVIarek-MartynovIRIvanishinaNSAssessment of vasomotor endothelial function in patients with diabetes mellitus type 1 at different stages of diabetic nephropathyTer Arkh200375172112920953
   PubMed Web of Science ®Google Scholar
• ShestakovaMVIarek-MartynovaIRIvanishinaNSCardiorenal syndrome in type 1 diabetes mellitus: the role of endothelial dysfunctionKardiologiia2005a45354116007033
   PubMed Web of Science ®Google Scholar
• ShestakovaMVJarek-MartynowaIRIvanishinaNSRole of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 DiabetesRes Clin Pract2005b68Suppl 1S6572
   PubMed Web of Science ®Google Scholar
• SkrhaJVackovaIKvasnickaJPlasma-free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitusEur J Clin Invest19902017162112482
   PubMed Web of Science ®Google Scholar
• Skyrme-JonesRAMeredithITSoluble adhesion molecules, endothelial function and vitamin E in type 1 diabetesCoron Artery Dis200112697511211168
   PubMed Web of Science ®Google Scholar
• Skyrme-JonesRAO’BrienRCLuoMEndothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetesJ Am Coll Cardiol200035292910676672
   PubMed Web of Science ®Google Scholar
• SourijHZweikerRWascherTCEffects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetesDiabetes Care20062910394516644634
   PubMed Web of Science ®Google Scholar
• StalkerTJSkvarkaCBScaliaRA novel role for calpains in the endothelial dysfunction of hyperglycemiaFASEB J20031715111312824289
   PubMed Web of Science ®Google Scholar
• StehouwerCDFischerHRvan KuijkAWEndothelial dysfunction precedes development of microalbuminuria in IDDMDiabetes19954456147729616
   PubMed Web of Science ®Google Scholar
• SteinbergHOBrechtelGJohnsonAInsulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide releaseJ Clin Invest199494117298083357
   PubMed Web of Science ®Google Scholar
• SteinbergHOChakerHLeamingRObesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistanceJ Clin Invest1996972601108647954
   PubMed Web of Science ®Google Scholar
• SteinbergHOTarshobyMMonestelRElevated circulating free fatty acid levels impair endothelium-dependent vasodilationJ Clin Invest1997100123099276741
   PubMed Web of Science ®Google Scholar
• StuddyPRLapworthRBirdRAngiotensin-converting enzyme and its clinical significance-a reviewJ Clin Pathol198336938476308066
   PubMed Web of Science ®Google Scholar
• StuhlingerMCAbbasiFChuJWRelationship between insulin resistance and an endogenous nitric oxide synthase inhibitorJAMA20022871420611903029
   PubMed Web of Science ®Google Scholar
• TamaiOMatsuokaHItabeHSingle LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humansCirculation19979576828994420
   PubMed Web of Science ®Google Scholar
• TanKCChowWSAiVHEffects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion intype 2 diabetic patients with microalbuminuriaDiabetes Metab Res Rev20021871611921421
   PubMed Web of Science ®Google Scholar
• TanKCChowWSTamSCAtorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitusJ Clin Endocrinol Metab200287563811836286
   PubMed Web of Science ®Google Scholar
• TargherGBertoliniLZenariLCigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetesDiabetes Care200023524810857946
   PubMed Web of Science ®Google Scholar
• TarnowLHovindPTeerlinkTElevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesDiabetes Care20043273765914988299
   PubMed Web of Science ®Google Scholar
• TaddeiSVirdisAGhiadoniLEffects of antihypertensive drugs on endothelial dysfunction: clinical implicationsDrugs2002622658411817973
   PubMed Web of Science ®Google Scholar
• TesfamariamBBrownMLCohenRAElevated glucose impairs endothelium-dependent relaxation by activating protein kinaseJ Clin Invest199187164382022734
   PubMed Web of Science ®Google Scholar
• TesfamariamBCohenRAFree radicals mediate endothelial cell dysfunction caused by elevated glucoseAm J Physiol19922632 Pt 2H32161510128
   PubMedGoogle Scholar
• ThompsonGRMaherVMMatthewsSFamilial Hypercholesterolaemia Regression Study: a randomised trial of low-densitylipoprotein apheresisLance199534581116
   PubMed Web of Science ®Google Scholar
• ThorandBBaumertJChamblessLMONICA/KORA Study GroupElevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general populationArterioscler Thromb Vasc Bio20062639840516322530
   PubMed Web of Science ®Google Scholar
• ToikkaJOAhotupaMViikariJSAConstantly low HDLcholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young menAtherosclerosis1999147133810525134
   PubMed Web of Science ®Google Scholar
• ToopMJDallingerKJJenningsPEAngiotensin-converting enzyme (ACE): relationship to insulin-dependent diabetes and microangiopathyDiabet Med1986345573030621
   PubMed Web of Science ®Google Scholar
• TracyRPLemaitreRNPsatyBMRelationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion ProjectArterioscler Thromb Vasc Biol199717112179194763
   PubMed Web of Science ®Google Scholar
• TsukaharaHSekineKUchiyamaMFormation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetesPediatr Res2003544192412761359
   PubMed Web of Science ®Google Scholar
• TsunekawaTHayashiTKanoHCerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 daysCirculation2001104376911468195
   PubMed Web of Science ®Google Scholar
• TsunekawaTHayashiTKanoHCerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 daysCirculation2001104376911468195
   PubMed Web of Science ®Google Scholar
• TummalaPEChenX-LSundellCLAngiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the reninangiotensin system and atherosclerosisCirculation19991001223910484544
   PubMed Web of Science ®Google Scholar
• UittenbogaardAShaulPWYuhannaISHigh-density lipoprotein prevents oxidized low-density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolaeJ Biol Chem2000275112788310753938
   PubMed Web of Science ®Google Scholar
• VaccaroOPernaAFManciniFPPlasma homocysteine and microvascular complications in type 1 diabetesNutr Metab Cardiovasc Dis20001029730411302003
   PubMed Web of Science ®Google Scholar
• Van de ReeMAHuismanMVDe ManFHImpaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatinCardiovasc Res20015229930511684078
   PubMed Web of Science ®Google Scholar
• Van EttenRWde KoningEJHoningMLIntensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetesArterioscler Thromb Vasc Biol20022279980412006393
   PubMed Web of Science ®Google Scholar
• Van VenrooijFVvan de ReeMABotsMLAtorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trialDiabetes Care20022512111612087021
   PubMed Web of Science ®Google Scholar
• VehkavaaraSMakimattilaSSchlenzkaAInsulin therapy improves endothelial function in type 2 diabetesArterioscler Thromb Vasc Biol2000205455010669655
   PubMed Web of Science ®Google Scholar
• VehkavaaraSYki-JarvinenH3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetesArterioscler Thromb Vasc Biol2004243253014684428
   PubMed Web of Science ®Google Scholar
• VerrottiAGrecoRBascianiFvon Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuriaPediatr Res200353382612595584
   PubMed Web of Science ®Google Scholar
• VibertiGCBenigniABognettiEGlomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitusDiabet Med19896219232523782
   PubMed Web of Science ®Google Scholar
• WakinoSLawREHsuehWAVascular protective effects by activation of nuclear receptor PPARJ Diabetes Complications20021646911872366
   PubMed Web of Science ®Google Scholar
• WatanabeYSunayamaSShimadaKTroglitazone improves endothelial dysfunction in patients with insulin resistanceJ Atheroscler Thromb200071596311480457
   PubMedGoogle Scholar
• WattsGFPlayfordDADyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: a hypothesisAtherosclerosis199814117309863535
   PubMed Web of Science ®Google Scholar
• WautierJLSetiadiHViletteDLeukocyte adhesion to endothelial cellsBiorheology199027425322261508
   PubMed Web of Science ®Google Scholar
• WautierJLWautierMPPintignyDFactors involved in cell adhesion to vascular endotheliumBlood Cells19839221346198016
   PubMedGoogle Scholar
• WautierJLZoukourianCChappeyOReceptor mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic ratsJ Clin Invest199697238438550841
   PubMed Web of Science ®Google Scholar
• WenYSkidmoreJCPorter-TurnerMMRelationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetesDiabetes Obes Metab20024305812190993
   PubMed Web of Science ®Google Scholar
• WilliamsBA potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?Miner Electrolyte Metab19982440059930379
   PubMedGoogle Scholar
• WilliamsSBCuscoJARoddyMAImpaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJ Am Coll Cardiol199627567748606266
   PubMed Web of Science ®Google Scholar
• WiltshireEThomasDWBaghurstPReduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetesJ Pediatr20011388889311391334
   PubMed Web of Science ®Google Scholar
• WiltshireEJGentRHirteCPenaAEndothelial dysfunction relates to folate status in children and adolescents with type 1 diabetesDiabetes2002512282612086961
   PubMed Web of Science ®Google Scholar
• XiXPGrafKGoetzeSCentral role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cellsArterioscler Thromb Vasc Biol19991973829888869
   PubMed Web of Science ®Google Scholar
• XiangGDHeYSDaiXJAngiotensin-converting enzyme gene and the brachial artery endothelial dysfunction in type 2 diabetes without angiopathyZhonghua Yi Xue Yi Chuan Xue Za Zhi200421355915300633
   PubMedGoogle Scholar
• YaqoobMPatrickAWMcClellandPRelationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitusClin Sci (Colch)199385557628287643
   PubMedGoogle Scholar
• YokotaTOritaniKTakahashiIAdiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophagesBlood20009617233210961870
   PubMed Web of Science ®Google Scholar
• YuYSuoLYuHInsulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuriaDiabetes Res Clin Pract2004659510415223221
   PubMed Web of Science ®Google Scholar
• YusufSGersteinHHoogwerfBRamipril and the development of diabetesJAMA20012861882511597291
   PubMed Web of Science ®Google Scholar
• ZengGNystromFHRavichandranLVRoles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cellsCirculation200010115394510747347
   PubMed Web of Science ®Google Scholar
• ZoppiniGTargherGCacciatoriVChronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patientsDiabetes Care1999221871410546022
   PubMed Web of Science ®Google Scholar
• ZoukourianCWautierMPChappeyOEndothelial cell dysfunction secondary to the adhesion of diabetic erythrocytes. Modulation by iloprostInt Angiol1996151952008971575
   PubMed Web of Science ®Google Scholar